Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation-predominant Irritable Bowel Syndrome

NCT00945334 is registered in ClinicalTrials.gov with Mark Pimentel, MD as lead sponsor.

NCT NCT00945334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00945334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Placebo Controlled Trial Comparing Neomycin to Rifaximin Plus Neomycin in the Treatment of Methane Positive Subjects With Constipation-predominant Irritable Bowel Syndrome
Lead sponsor
Mark Pimentel, MD
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2009
Completion date
June 30, 2013
Enrollment
37 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

constipation-predominant irritable bowel syndrome